Fig. 7From: EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumoursTime–activity curves for the tumour after the first (a) and the second administration (b). Time–activity curves for the liver after the first (c) and the second administration (d)Back to article page